Intravenous Dose-Escalation Study With ETI-204 in Adult Volunteers

Clinical trial NCT00829582 · COMPLETED

Trial details

NCT number: NCT00829582
Sponsor: Elusys Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2009-02-01
Primary completion: 2009-07-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.